WEREWOLF THERAPEUTICS
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
WEREWOLF THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.werewolftx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
128.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Anavo Therapeutics
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Aortyx
The ultimate solution for aortic diseases
Janpix
Janpix operates as an oncology-focused startup.
Nuntius Therapeutics
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.
Quell Therapeutics
Quell Therapeutics is a cell therapy company
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Swing Therapeutics
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
Teewinot Life Sciences
Teewinot Life Sciences Corporation is a biopharmaceutical company
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MPM Capital
MPM Capital investment in Series B - Werewolf Therapeutics
UPMC Enterprises
UPMC Enterprises investment in Series B - Werewolf Therapeutics
Longwood Fund
Longwood Fund investment in Series B - Werewolf Therapeutics
DC Investment Partners
DC Investment Partners investment in Series B - Werewolf Therapeutics
Taiho Ventures
Taiho Ventures investment in Series B - Werewolf Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Werewolf Therapeutics
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Series B - Werewolf Therapeutics
Soleus Capital
Soleus Capital investment in Series B - Werewolf Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Werewolf Therapeutics
Adage Capital Management
Adage Capital Management investment in Series B - Werewolf Therapeutics
Official Site Inspections
http://www.werewolftx.com Semrush global rank: 2.63 M Semrush visits lastest month: 6.5 K
- Host name: 78.124.199.104.bc.googleusercontent.com
- IP address: 104.199.124.78
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Werewolf Therapeutics" on Search Engine
Werewolf Therapeutics Provides Business Update and Highlights …
WATERTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics | LinkedIn
About us. We are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments. Website. http://www.werewolftx.com. Industry. …See details»
Werewolf Therapeutics Provides Business Update and Highlights …
Werewolf Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune …See details»
Werewolf Therapeutics Announces WTX-124 Clinical Abstract …
Werewolf Therapeutics, Inc., is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the …See details»
Werewolf Therapeutics Reports Fourth Quarter 2021 and Full …
CAMBRIDGE, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics to Present First-of-Its-Kind Data
WATERTOWN, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Announces Upcoming Presentations at …
WATERTOWN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Provides Business Update and Highlights …
WATERTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Presents First Preclinical Data …
Werewolf Therapeutics, Inc., is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the …See details»
Werewolf Therapeutics to Present Clinical and Preclinical
WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Announces Upcoming Presentations at …
WATERTOWN, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Presents Preclinical Results …
WATERTOWN, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics Reports Fourth Quarter and Full Year …
WATERTOWN, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical …See details»
Werewolf Therapeutics - Crunchbase Company Profile & Funding
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the …See details»
| Werewolf Therapeutics, Inc.
| Werewolf Therapeutics, Inc. Investors. Overview News & Resources Stock Information SEC Filings Corporate Governance Contact & FAQs. Werewolf Therapeutics Presents …See details»
Werewolf Therapeutics - Nature
Werewolf Therapeutics. werewolftx.com. Designing conditionally activated immune stimulators that attack cancer cells. Using its proprietary PREDATOR protein …See details»
Werewolf Therapeutics Announces WTX-124 Clinical Abstract
Werewolf Therapeutics, Inc. announced that an abstract providing an update of the Company’s ongoing monotherapy and combination Phase 1/1b study of WTX-124, its …See details»
Werewolf Therapeutics - Funding, Financials, Valuation & Investors
Their latest funding was raised on May 10, 2022 from a Post-IPO Secondary round. Werewolf Therapeutics is registered under the ticker NASDAQ:HOWL . Their stock …See details»
Werewolf Therapeutics | CipherBio
Werewolf Therapeutics is an MPM-founded preclinical-stage biotech developing novel immuno-stimulatory therapeutics to more precisely and effectively stimulate anti-tumor …See details»
Werewolf Therapeutics - Tech Stack, Apps, Patents
Overview. The intellectual property of Werewolf Therapeutics includes 17 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. …See details»